Nick Woolf
Pharma
North Georgia Diabetes and Endocrinology: Cumming
Australia
Biography
Nick Woolf joined the company in September 2013. He is an accomplished business executive, bringing two decades of biotechnology and pharmaceutical industry experience to Suda. He has a strong track record in structuring, negotiating and executing successful alliances, licensing agreements and M&A transactions as well as providing business development, management and strategic leadership to organisations. Nick was most recently Chief Financial Officer and Vice President of Corporate Development of Phylogica Limited based in Western Australia. Prior to Phylogica, Nick was Chief Business Officer of a leading UK-based biopharmaceutical company, Oxford BioMedica plc. He began his career as a healthcare investment banker and was formerly head of European biotech equity research at ABN Amro. Mr Woolf holds a MA in Chemistry from Oxford University and is a qualified accountant.
Research Interest
Life science
